(Q36714648)

English

The epidemiology of pneumococcal, meningococcal, and Haemophilus disease in the Middle East and North Africa (MENA) region--current status and needs

scientific article published on 27 November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

The epidemiology of pneumococcal, meningococcal, and Haemophilus disease in the Middle East and North Africa (MENA) region--current status and needs (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

0 references

0 references

author name string

William P Hausdorff

1

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Rana Hajjeh

2

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Abdulrahman Al-Mazrou

3

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Atef Shibl

4

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Montse Soriano-Gabarro

5

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Middle East & North Africa Vaccine-Preventable Diseases Regional Advisory Group

6

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

language of work or name

0 references

publication date

27 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1935-1944

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

Meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolated in Algiers, Algeria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

Etiology, antimicrobial susceptibility profiles, and mortality associated with bacterial meningitis among children in Egypt

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

The changing epidemiology of meningococcal meningitis after introduction of bivalent A/C polysaccharide vaccine into school-based vaccination programs in Egypt

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae causing meningitis in Egypt, 1998-2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

Meningitis and encephalitis at the Abbassia Fever Hospital, Cairo, Egypt, from 1966 to 1989.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

Bacterial meningitis: still a cause of high mortality and severe neurological morbidity in childhood.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

Health risks at the Hajj

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

Serogroup W-135 meningococcal disease during the Hajj, 2000

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

Streptococcus pneumoniae serotypes/serogroups causing invasive disease in Riyadh, Saudi Arabia: extent of coverage by pneumococcal vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

Bacteriology of community acquired meningitis in Sfax, Tunisia (1993-2001)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

Pattern of meningitis in Al-Ain medical district, United Arab Emirates--a decadal experience (1990-99).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

Bacterial pneumonia vaccines and childhood pneumonia: are we winning, refining, or redefining?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

Bacteremia among children admitted to a rural hospital in Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.018

7 January 2021

Identifiers

10.1016/J.VACCINE.2006.11.018

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36714648&oldid=1647228637"